References
- Kapp N, von Hertzen H. Medical methods to induce abortion in the second trimester. In: Paul M, Lichtenberg ES, Borgatta L, et al., editors. Management of unintended and abnormal pregnancy. Comprehensive comprehensive abortion care. Oxford: Blackwell; 2009. p. 178–192.
- Gemzell-Danielsson K, Lalitkumar S. Second trimester medical abortion with mifepristone–misoprostol and misoprostol alone: a review of methods and management. Reprod Health Matters. 2008;16:162–172.
- World Health Organization. Safe abortion: technical and policy guidance for health systems. Geneva: WHO; 2012.
- Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database Syst Rev. 2008;1:CD006714. doi: 10.1002/14651858.
- Weeks A, Faundes A. Misoprostol in obstetrics and gynecology. Int J Gynaecol Obstet. 2007;99 (Suppl. 2):S156–S159.
- Bracken H, editor. Providing medical abortion in low-resource settings: an introductory guidebook. 2nd ed. New York: Gynuity Health Projects; 2009.
- Wildschut H, Both MI, Medema S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;1:CD005216. doi: 10.1002/14651858.
- International Federation of Gynecology and Obstetrics. Misoprostol recommended dosages [Internet]. 2012 [cited 30 Jun 2015]. Available from: www.figo.org/sites/default/files/uploads/project-publications/Miso/Misoprostol_Recommended%20Dosages%202012.pdf.
- Lalitkumar S, Bygdeman M, Gemzell-Danielsson K. Mid-trimester induced abortion: a review. Hum Reprod Update. 2007;13:37–52.
- Louie KS, Chong E, Tsereteli T, et al. The introduction of first trimester medical abortion in Armenia. Reprod Health Matters. 2015;22:56–66.
- Dabash R, Chelli H, Hajri S, et al. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14–21 weeks of pregnancy. Int J Gynaecol Obstet. 2015;130:40–44.
- American College of Obstetricians and Gynaecologists, American Institute of Ultrasound in Medicine, Society for Maternal-Fetal Medicine. Committee opinion no 611: method for estimating due date. Obstet Gynecol. 2014;124:863–866.
- Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based clinical guideline number 7. London: RCOG; 2011.
- Schaff E. Evidence for shortening the time interval of prostaglandin after mifepristone for medical abortion. Contraception. 2006;74:42–44.
- Shaw KA, Topp NJ, Shaw JG, et al. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review. Obstet Gynecol. 2013;121:1335–1347.
- Ngoc NT, Shochet T, Raghavan S, et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol. 2011;118:601–608.
- Ashok PW, Templeton A, Wagaarachchi PT, et al. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception. 2004;69:51–58.
- Hamoda H, Ashok PW, Flett GM, et al. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. BJOG. 2004;111:996–1000.
- Meckstroth KR, Whitaker AK, Bertisch S, et al. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol. 2006;108:582–590.
- Middleton T, Schaff E, Fielding SL, et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception. 2005;72:328–332.
- Ellis SC, Kapp N, Vragpvoc O, et al. Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion. Contraception. 2010;81:441–445.
- Garg G, Takkar N, Sehgal A. Buccal versus vaginal misoprostol administration for the induction of first and second trimester abortions. J Obstet Gynaecol India. 2015;65:111–116.
- American College of Obstetricians and Gynaecologists. ACOG practice bulletin no. 135: second-trimester abortion. Obstet Gynecol. 2013;121:1394–1406.